Cardiol Therapeutics' CardiolRx shows promise in treating heart conditions. Click here to read more about CRDL stock and why ...

Channel Seven reporter Denham Hitchcock has announced his return to the network’s Spotlight program, after stepping away two ...

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks.

Former Seven presenter Denham Hitchcock has announced his return to air, two years after calling it quits to sail around the ...

Kiniksa Pharmaceuticals stock is attractive because it trades near 52-week lows, and its marketed drug gains traction. Click to find out why KNSA is a Hold.

But suddenly Braxton found herself being rushed to the hospital. There,doctors told her she had pericarditis, a serious heart condition. Often caused by a virus, pericarditis is an inflammation of ...

Pain between the shoulder blades is a frequent complaint that can arise from a variety of factors, some minor and others more ...

Poster highlights robust, dose-dependent endoscopic response with VTX958 and reductions in key inflammatory markersFull analysis of Phase 2 ...

Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) and it is also prescribed for specific inflammatory conditions that ...

Following an admission to the authors’ centre with severe anaemia, duodenal biopsy confirmed the diagnosis of Whipple’s ...

Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have received a consensus recommendation of “Buy” ...

Ventyx Biosciences Inc. (VTYX) stock has reached a 52-week low, trading at $1.57, marking a significant downturn for the biopharmaceutical company. With a market capitalization of $114.5 million, the ...